ABCG2 and leukemia: However, it must be considered that ABCG2 overexpression may also contribute to the negative prognosis by conferring stem cell-like properties to leukemia cells, thus favoring the persistence of disease in the hypoxic bone marrow niche and accounting for “late” relapses occurring after chemotherapy intensification and stem cell transplantation.